Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions

Brief summary (registry, in English)

This study assesses the long?term effectiveness of adalimumab in subjects starting a treatment for ulcerative colitis in real life conditions, namely to describe the time to loss of clinical benefit in a time to event approach.

What you commit to

• Study type: Observational
• Participants enrolled: 265
• From 29 Apr 2016 to the primary completion date, 15 Dec 2023
• 80 sites in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (80)

Sites in registry order. Save your city in your profile to sort them by distance.